≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Iron deficiency

DOID Endpoint Browser PheWeb

E4_FE_DEF

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E61.1#
  • Cause of death: ICD-10 — E61.1#

2 out of 7 registries used, show all original rules.

809

4. Check minimum number of events

None

809

5. Include endpoints

None

809

6. Filter based on genotype QC (FinnGen only)

809

Control definitions (FinnGen only)

Control exclude
E4_NUTRIDEF

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E61
Name in latin
Sideropenia

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3324 2703 601
Only index persons 2876 2502 374
Unadjusted period prevalence (%)
Whole population 0.07 0.08 0.02
Only index persons 0.08 0.09 0.01
Median age at first event (years)
Whole population 33.31 36.44 19.09
Only index persons 40.25 37.72 57.20

-FinnGen-

Key figures

All Female Male
Number of individuals 809 713 96
Unadjusted period prevalence (%) 0.22 0.24 0.04
Median age at first event (years) 41.57 38.36 65.41

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
623
Matched controls
6228
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E61.1
ICD-10 Finland
Iron deficiency
+∞
323.0
623
73
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
11.7
83.1
165
186
E66.8
ICD-10 Finland
Other obesity
59.3
54.9
64
12
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.4
52.0
238
774
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
+∞
48.6
46
*
E66.01
ICD-10 Finland
Obesity due to excess calories
17.8
44.2
70
44
R53
ICD-10 Finland
Malaise and fatigue
3.5
36.8
215
817
D64.9
ICD-10 Finland
Anaemia, unspecified
5.5
24.7
77
157
UJF32
NOMESCO Finland
Coloscopy
3.1
24.4
158
619
B03BA03
ATC
hydroxocobalamin; parenteral
7.8
24.3
57
79
D50.8
ICD-10 Finland
Other iron deficiency anaemias
15.3
23.7
39
27
E66.00
ICD-10 Finland
Metabolic syndrome
25.8
23.3
32
13
UJF30
NOMESCO Finland
Ileoscopy through colon
3.9
19.6
86
247
B02AA02
ATC
tranexamic acid; systemic
2.8
19.5
141
583
UJF92
NOMESCO Finland
Capsular endoscopy
9.0
18.9
40
47
E66.9
ICD-10 Finland
Obesity, unspecified
28.9
18.9
25
9
D50
ICD-10 Finland
Iron deficiency anaemia
7.7
18.8
44
61
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
2.9
17.4
114
441
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
15.7
217
1238
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
15.2
159
795
B81
ICPC
Anaemia vit B12/folate deficiency
9.8
15.1
30
32
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
7.6
14.7
34
47
A02BC02
ATC
pantoprazole; systemic
2.0
14.6
357
2533
G47.3
ICD-10 Finland
Sleep apnoea
3.0
14.5
91
340
A02BC05
ATC
esomeprazole; systemic
2.0
14.2
236
1441
ZX120
NOMESCO Finland
Intravenous
3.3
14.0
73
241
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
13.8
71
232
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
143.0
13.5
14
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
12.8
263
1724
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.2
12.2
47
120
A10BA02
ATC
metformin; oral
2.5
12.2
103
460
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
4.3
11.8
44
109
N02AJ06
ATC
codeine and paracetamol; systemic
1.9
11.8
230
1469
R01AD12
ATC
fluticasone furoate; nasal
1.9
11.7
239
1553
WVA20
NOMESCO Finland
Medicine administration
7.7
11.5
26
35
WX002
NOMESCO Finland
Sedation and analgesia
2.4
11.4
108
510
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
11.4
117
575
SPAT1262
SPAT
Handing over of treatment supplies
2.5
11.3
90
389
QBJ30
NOMESCO Finland
Correction of abdominal apron
20.5
11.2
16
8
N02AX02
ATC
tramadol; systemic, rectal
1.9
11.1
202
1251
B80
ICPC
Iron deficiency anaemia
5.7
11.0
31
57
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
3.0
11.0
64
228
R06.0
ICD-10 Finland
Dyspnoea
2.1
10.7
128
670
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
3.1
10.6
57
193
3AC01
NOMESCO Finland
NA
9.4
10.6
21
23
A04
ICPC
Weakness/tiredness general
2.2
10.5
111
551
R03AC02
ATC
salbutamol; inhalant
1.7
10.3
343
2571
H02AB06
ATC
prednisolone; systemic
1.8
10.2
258
1777
N06AX16
ATC
venlafaxine; oral
2.2
10.1
106
525
O99.0
ICD-10 Finland
Anaemia complicating pregnancy, childbirth and the puerperium
5.8
9.9
27
48
H03AA01
ATC
levothyroxine sodium; systemic
2.0
9.8
152
882
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.3
9.8
91
425
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
2.1
9.6
113
585
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
9.1
128
711
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.6
9.0
67
279
N06AX12
ATC
bupropion; oral
2.7
8.8
59
230
J45
ICD-10 Finland
Asthma
2.4
8.7
73
322
103
Kela drug reimbursment
Diabetes, insulin-treated
2.2
8.7
92
455
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.4
8.4
74
333
R03BB04
ATC
tiotropium bromide; inhalant
3.1
8.3
44
148
N05BA04
ATC
oxazepam; oral
1.8
8.3
152
932
N04BC05
ATC
pramipexole; oral
3.4
8.2
38
116
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.7
8.2
242
1715
R4190
NOMESCO Finland
Nutritional therapy
4.6
8.1
27
61
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
8.0
193
1287
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
13.2
7.9
13
10
N06AX26
ATC
vortioxetine; oral
2.7
7.9
54
215
N06AX11
ATC
mirtazapine; oral
1.7
7.8
184
1219
M03BX02
ATC
tizanidine; oral
1.6
7.7
355
2811
WX402
NOMESCO Finland
General anaesthesia
2.0
7.7
104
570
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.3
7.6
72
338
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.1
7.6
87
443
SPAT1310
SPAT
Counselling related to known health issue
1.7
7.6
206
1420
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
7.5
121
705
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
7.4
348
2760
A02BC01
ATC
omeprazole; systemic
1.8
7.4
149
939
SPAT1263
SPAT
Sampling
1.6
7.4
280
2104
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
5.5
7.3
20
37
A07EA06
ATC
budesonide; oral, local oral
3.4
7.2
33
101
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.9
7.1
110
633
T82
ICPC
Obesity
4.2
7.1
25
61
SPAT1301
SPAT
No procedures
1.7
7.1
196
1350
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.6
7.0
50
204
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
7.0
170
1126
M54.5
ICD-10 Finland
Low back pain
1.7
7.0
198
1371
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.1
6.9
83
434
I50.9
ICD-10 Finland
Heart failure, unspecified
3.0
6.9
37
127
SPAT1139
SPAT
Nutrition survey
4.5
6.9
23
53
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
6.9
55
239
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
6.8
102
578
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.0
6.7
93
514
T90
ICPC
Diabetes non-insulin dependent
2.1
6.6
70
347
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.5
6.6
50
212
N05CF01
ATC
zopiclone; oral
1.7
6.6
143
918
A02BC04
ATC
rabeprazole; oral
2.4
6.5
54
238
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
6.5
145
938
R42
ICD-10 Finland
Dizziness and giddiness
1.9
6.4
104
606
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.9
6.4
99
569
J01AA02
ATC
doxycycline; systemic
1.6
6.4
415
3500
C03CA01
ATC
furosemide; systemic
2.1
6.4
76
394
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.7
6.4
26
73
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.9
6.3
89
494
Z01.7
ICD-10 Finland
Laboratory examination
2.1
6.3
68
342
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.3
6.3
58
270
E66.0
ICD-10 Finland
Obesity due to excess calories
+∞
6.3
6
*
A10BH01
ATC
sitagliptin; oral
3.1
6.2
31
102
UJD02
NOMESCO Finland
Gastroscopy
3.6
6.2
26
75
D64.8
ICD-10 Finland
Other specified anaemias
7.8
6.1
13
17
OAB72
NOMESCO Finland
Weight control and weight loss guidance
12.7
6.1
10
8
B01AB05
ATC
enoxaparin; parenteral
1.7
6.1
124
780
K30
ICD-10 Finland
Functional dyspepsia
2.1
6.1
66
331
N06AB04
ATC
citalopram; systemic
1.8
6.1
119
739
XW000
NOMESCO Finland
Bone marrow biopsy
4.0
6.0
22
56
A10BH05
ATC
linagliptin; oral
5.6
6.0
16
29
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
6.0
267
2050

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3004789) Transferrin [Mass/volume] in Serum or Plasma
428
705
11.77
281.48
3.5
2.2
g/l
2.5
2.5
2.11
410
634
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
399
633
11.46
269.00
3.5
2.3
%
22.3
24.0
1.27
352
533
(3022948) Iron [Moles/volume] in Serum or Plasma
441
793
11.03
268.11
3.6
2.2
umol/l
13.3
14.7
2.89
425
715
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
554
1581
8.94
210.74
3.6
2.0
mg/l
2.7
2.6
0.29
505
1350
(3001122) Ferritin [Mass/volume] in Serum or Plasma
776
3900
25.26
146.90
8.0
2.8
ug/l
49.5
60.7
2.05
758
3668
(3027945) Reticulocytes/100 erythrocytes in Blood
213
466
5.85
96.65
2.3
3.2
%
1.7
1.7
0.11
185
416
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
473
1969
4.38
94.47
2.5
1.7
pmol/l
95.4
97.2
0.37
292
1072
(3023520) Reticulocytes [#/volume] in Blood
168
310
6.58
90.79
2.4
2.8
e9/l
74.4
68.7
0.93
119
222
(40768797) Stomach Pathology biopsy report
251
708
4.69
83.29
1.3
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
327
1140
4.14
81.38
1.8
1.4
nmol/l
21.0
21.3
0.10
294
1001
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
432
1965
3.57
69.79
1.6
1.3
u/ml
1.1
1.7
0.64
140
523
(3019309) Folate [Moles/volume] in Red Blood Cells
241
750
4.15
68.84
2.1
1.6
nmol/l
1213.5
1142.3
0.56
183
563
(42870588) Differential panel, method unspecified - Blood
424
1982
3.39
64.09
6.5
5.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
276
1032
3.54
59.06
2.0
1.5
pmol/l
27659981.5
33482076.6
0.07
235
899
(3007164) IgA [Mass/volume] in Serum or Plasma
372
1672
3.27
58.85
1.7
1.4
g/l
2.0
2.1
0.49
268
1038
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
477
2562
3.10
53.93
3.3
2.1
nmol/l
76.2
73.7
1.25
450
2387
(3024561) Albumin [Mass/volume] in Serum or Plasma
404
2016
3.01
51.50
5.6
4.4
g/l
36.1
36.9
2.21
367
1879
(3006504) Eosinophils/100 leukocytes in Blood
526
3061
3.05
50.07
6.8
5.4
%
2.9
2.7
1.36
504
2868
(3019069) Monocytes/100 leukocytes in Blood
527
3082
3.04
49.49
7.1
5.6
%
8.1
7.9
0.52
511
2913
(3001604) Monocytes [#/volume] in Blood
544
3241
3.07
49.31
6.4
5.5
e9/l
0.5
0.5
0.00
501
2872
(3006315) Basophils [#/volume] in Blood
544
3249
3.06
48.93
6.5
5.5
e9/l
0.0
0.0
0.11
498
2873
(3013115) Eosinophils [#/volume] in Blood
556
3370
3.08
48.50
6.7
5.8
e9/l
0.2
0.2
0.30
514
3031
(3022096) Basophils/100 leukocytes in Blood
510
2952
2.97
48.39
6.9
5.5
%
0.6
0.7
0.21
491
2762
(3002030) Lymphocytes/100 leukocytes in Blood
539
3231
3.00
47.61
6.9
5.4
%
29.8
30.1
0.24
520
3051
(3019198) Lymphocytes [#/volume] in Blood
555
3388
3.03
47.25
6.5
5.4
e9/l
1.9
2.0
0.63
513
3066
(3018010) Neutrophils/100 leukocytes in Blood
534
3197
2.97
47.05
6.6
5.2
%
55.6
56.0
0.45
517
3021
(3048689) Calprotectin [Mass/mass] in Stool
249
1045
3.00
41.93
3.0
2.4
ug/g
97.6
85.2
0.47
198
814
(3013650) Neutrophils [#/volume] in Blood by Automated count
572
3708
2.85
40.58
7.7
8.0
e9/l
3.9
3.9
0.08
530
3280
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
427
2415
2.63
39.62
7.5
6.0
mmol/l
1.2
1.2
0.87
311
2038
(3036481) Cortisol [Moles/volume] in Serum or Plasma
174
617
3.32
38.85
2.0
2.0
nmol/l
407.7
390.1
0.53
163
579
(3013826) Glucose [Moles/volume] in Serum or Plasma
518
3243
2.66
38.52
5.3
4.2
mmol/l
6.1
6.2
0.27
439
2858
(3012095) Magnesium [Moles/volume] in Serum or Plasma
181
661
3.24
38.46
4.9
3.9
mmol/l
0.8
0.8
0.75
167
621
(3022145) Colonoscopy Study observation
167
592
3.29
37.19
1.5
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
150
503
3.43
36.49
3.5
3.3
pmol/l
4.6
4.6
0.08
142
455
(3003458) Phosphate [Moles/volume] in Serum or Plasma
148
495
3.44
36.13
5.9
6.9
mmol/l
1.0
1.1
2.10
140
459
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
385
2149
2.51
35.64
6.7
5.6
mmol/l
1.2
1.2
1.29
345
1952
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
182
695
3.09
35.62
1.9
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
607
4320
2.62
31.22
7.7
5.9
u/l
77.0
73.3
0.69
574
4025
(3013707) Erythrocyte sedimentation rate by Westergren method
638
4662
2.74
30.88
4.7
3.5
mm/h
9.7
8.9
0.92
600
4333
(40760892) CBC W Ordered Manual Differential panel - Blood
314
1707
2.37
29.49
3.5
3.8
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
147
550
3.04
29.43
1.6
1.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
133
470
3.19
29.36
3.3
4.0
u/l
210.3
258.9
1.85
121
446
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
38
46
8.62
29.32
2.0
1.6
pg
31.8
32.3
0.28
38
46
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
709
5539
3.27
29.02
6.1
4.1
pmol/l
14.3
14.3
0.05
676
5146
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
431
2722
2.25
27.86
5.5
5.0
umol/l
11.4
10.9
0.21
397
2541
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
89
252
3.84
27.64
1.1
1.1
u/ml
1.8
5.7
0.84
13
44
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
299
1639
2.31
27.07
2.6
2.3
u/l
53.2
55.8
1.05
271
1510
(3032080) INR in Blood by Coagulation assay
305
1706
2.26
26.13
8.6
6.1
inr
1.1
1.1
0.07
127
597
(36660697) Celiac disease serology panel - Serum
162
680
2.73
26.01
1.3
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
267
1438
2.28
24.82
3.4
3.3
ph
7.4
7.4
0.14
78
276
(3015377) Calcium [Moles/volume] in Serum or Plasma
301
1715
2.20
24.27
2.5
2.9
mmol/l
2.3
2.3
2.72
273
1543
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
79
228
3.73
23.80
2.8
2.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
193
929
2.42
23.05
1.4
1.4
titre
345.6
572.4
1.91
39
206
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
754
6326
3.82
23.02
7.1
4.7
mu/l
1.6
1.9
1.00
724
5981
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
62
155
4.25
22.76
1.8
2.3
g/l
1.3
1.3
0.14
51
140
(3012501) Base excess in Blood by calculation
45
89
5.30
21.89
2.6
2.5
mmol/l
3.2
2.3
0.60
20
49
(3005719) IgG [Mass/volume] in Serum or Plasma
118
461
2.83
21.51
2.7
2.7
g/l
10.1
10.2
0.12
106
418
(3037467) Urinalysis macro (dipstick) panel - Urine
617
4752
2.26
21.43
5.2
3.9
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
141
607
2.60
21.24
2.0
1.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
462
3207
2.03
21.03
5.3
4.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
158
728
2.45
20.58
1.3
1.2
iu/ml
87.0
157.4
2.20
64
297
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
102
378
2.94
20.45
2.4
3.0
mmol/l
1.2
1.2
3.94
83
319
(3018677) aPTT in Platelet poor plasma by Coagulation assay
157
724
2.45
20.40
3.4
2.3
s
30.1
29.3
1.20
147
701
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
236
1323
2.11
19.03
1.9
1.9
u/l
110.1
187.8
0.91
224
1256
(3031040) Bacteria [#/volume] in Urine by Automated count
594
4600
2.10
18.94
5.5
3.9
e6/l
705.4
1706.8
—
7
59
(3026008) Bacteria identified in Urine by Culture
306
1898
1.98
18.57
2.6
2.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
771
6739
4.07
18.32
16.6
9.6
mg/l
18.2
19.4
0.53
648
5091
(1616796) Gas panel - Central venous blood
39
80
5.07
18.20
2.1
2.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
141
651
2.41
18.14
3.9
3.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
732
6261
2.78
17.13
16.4
9.6
mmol/l
139.4
139.4
0.23
720
6060
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
53
148
3.76
16.70
1.0
1.1
u/ml
2.0
2.7
0.40
34
78
(3028026) IgM [Mass/volume] in Serum or Plasma
90
355
2.73
15.97
1.8
1.9
g/l
1.3
1.4
0.14
83
325
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
315
2055
1.87
15.84
4.2
2.9
u/l
25.4
26.8
0.61
303
1964
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
25
39
6.58
15.45
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
95
393
2.61
15.33
1.6
1.7
mg/l
2.7
2.5
0.14
68
250
(3013139) Helicobacter pylori Ag [Presence] in Stool
102
438
2.52
15.24
1.2
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
728
6289
2.57
15.22
16.8
9.7
mmol/l
3.9
3.9
1.30
716
6068
(46235355) HIV 1 and 2 tests - Meaningful Use set
403
2869
1.81
15.02
2.4
2.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
409
2939
1.79
14.65
13.3
8.0
e9/l
0.0
0.0
0.28
348
2411
(3044889) 12 lead EKG panel
484
3657
1.81
14.60
3.5
2.8
—
—
—
0
0
(3026782) Osmolality of Urine
193
1100
1.99
14.36
2.8
2.5
mosm/kgh2o
543.9
549.5
0.13
173
936
(3023368) Bacteria identified in Blood by Culture
194
1115
1.97
14.06
4.4
3.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
342
2355
1.78
13.96
2.0
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
230
1412
1.88
13.62
2.7
1.8
mg/l
1.0
0.9
0.37
171
1015
(3009261) Glucose [Presence] in Urine by Test strip
458
3465
1.74
13.17
3.7
3.2
estimate
0.0
0.0
0.50
124
706
(3021601) Nitrite [Presence] in Urine by Test strip
454
3430
1.74
13.08
5.1
4.3
estimate
0.0
0.0
0.50
128
714
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
152
821
2.05
13.03
3.9
2.8
ng/l
880.9
261.3
0.33
78
464
(3041096) Erythrocytes [Presence] in Urine by Automated
300
2027
1.76
12.80
3.3
2.7
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
30
67
4.61
12.69
1.0
1.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
451
3422
1.72
12.60
3.7
3.1
estimate
0.0
0.0
0.50
124
700
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
58
205
2.97
12.59
4.0
3.8
g/l
3.8
3.4
1.32
52
194
(3006653) Thiamine [Moles/volume] in Blood
15
16
9.53
12.58
1.5
1.3
nmol/l
130.3
131.7
0.03
15
16
(3048929) Epstein Barr virus Ab [Presence] in Serum
84
362
2.47
12.41
1.3
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
560
4539
1.76
12.07
3.6
2.6
u/l
30.6
30.8
0.03
526
4326
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
102
485
2.26
12.06
2.1
1.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
215
1338
1.83
11.98
5.2
3.5
%
91.6
95.1
1.22
209
1300
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
100
473
2.27
11.97
2.1
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
366
2649
1.70
11.97
3.6
3.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
612
5097
1.82
11.94
5.6
3.9
mmol/mol
37.6
37.1
0.73
576
4813
(3026493) Urate [Moles/volume] in Serum or Plasma
197
1196
1.86
11.87
2.2
2.4
umol/l
4403.9
5613.0
0.15
171
1059
(3019832) Treponema pallidum Ab [Presence] in Serum
309
2140
1.72
11.87
2.1
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
226
1435
1.80
11.75
1.7
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
674
5807
1.96
11.56
4.1
3.2
mmol/l
5.5
5.5
0.18
622
5410
(3009542) Hematocrit [Volume Fraction] of Blood
743
6641
2.46
11.55
21.7
10.7
%
39.2
39.6
0.88
595
5518
(3003327) Ova and parasites identified in Stool by Light microscopy
72
300
2.54
11.41
1.8
1.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
69
284
2.56
11.22
2.1
2.5
g/l
66.4
67.4
0.51
61
266
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
154
879
1.93
11.16
4.1
3.1
ng/l
913.7
956.0
0.07
125
728
(3012516) Albumin [Mass/volume] in Urine
167
981
1.89
11.09
3.2
3.3
mg/l
841.0
146.7
0.67
111
657
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
118
616
2.07
11.00
4.2
2.6
umol/l
6.1
5.7
0.11
98
506
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
246
1637
1.72
10.71
3.5
2.8
ng/l
32.8
27.1
0.21
117
748
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
281
1943
1.68
10.59
3.1
2.9
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
69
292
2.49
10.59
3.2
2.5
umol/l
6.0
5.9
0.03
52
224
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
132
727
1.97
10.59
2.0
1.7
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
18
30
6.11
10.43
1.3
1.1
%
97.6
94.1
0.11
13
18
(3002582) Erythrocytes [#/volume] in Urine
252
1703
1.70
10.30
3.1
2.9
e6/l
50.9
99.3
0.51
210
1268
(3013512) EKG study
193
1219
1.77
10.02
3.7
2.8
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
29
77
3.87
9.84
2.9
2.8
umol/l
25.2
31.5
1.26
23
68
(3000850) Epithelial cells [#/volume] in Urine
187
1176
1.77
9.83
2.5
2.4
e6/l
10.2
9.3
0.24
166
1030
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
66
285
2.43
9.71
1.6
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
32
92
3.58
9.70
3.1
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
208
1354
1.72
9.66
3.3
3.5
mmol/l
8.3
7.8
0.57
178
1163
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
154
924
1.82
9.45
2.8
2.2
u/l
8466.7
6222.4
0.29
71
387
(40761511) CBC panel - Blood by Automated count
775
7166
2.94
9.41
19.3
9.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
229
1540
1.68
9.40
3.0
2.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
228
1537
1.67
9.25
3.1
2.8
e6/l
0.2
0.3
0.27
192
1123
(3020682) Albumin/Creatinine [Ratio] in Urine
166
1027
1.78
9.18
4.2
4.1
mg/mmol
7.2
12.2
1.07
113
667
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
17
32
5.41
8.71
1.4
1.1
%
94.6
92.8
0.08
12
20
(3037756) Immunofixation for Serum or Plasma
22
52
4.32
8.70
1.4
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
26
70
3.80
8.67
1.3
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
41
150
2.83
8.40
1.3
1.4
ug/g
398.5
334.2
1.05
25
78
(3050129) First trimester maternal screen panel - Serum or Plasma
149
916
1.77
8.36
1.6
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
752
6910
2.25
8.33
11.5
7.7
u/l
22.7
23.1
0.23
735
6677
(3034860) Kappa light chains.free [Mass/volume] in Serum
28
82
3.50
8.28
2.3
3.5
mg/l
38.0
128.7
0.60
17
65
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
28
82
3.50
8.28
2.1
3.5
mg/l
21.7
25.2
0.50
17
64
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
42
157
2.77
8.28
1.4
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
68
320
2.23
8.23
4.1
4.1
ng/l
79.1
72.2
0.30
60
287
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
91
481
2.00
8.15
3.1
2.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
27
79
3.50
8.00
2.3
2.5
%
17.7
16.8
—
9
33
(40758558) Short blood count panel - Blood
222
1536
1.61
7.95
7.5
6.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
51
215
2.46
7.92
5.2
3.6
%
135.8
166.8
2.46
44
208
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
43
167
2.66
7.89
1.2
1.4
u/ml
265.8
217.9
0.50
25
103
(3000012) Reticulocyte production index
14
24
5.92
7.87
1.3
1.8
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
40
150
2.75
7.85
1.4
1.4
u/ml
103.3
115.5
0.65
21
28
(3005322) IgE [Units/volume] in Serum or Plasma
95
517
1.95
7.83
1.6
1.3
u/ml
176.1
192.8
0.15
86
473
(3004588) Protein electrophoresis panel - Serum or Plasma
50
211
2.46
7.75
2.4
2.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
44
175
2.60
7.71
1.2
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
67
323
2.17
7.65
1.7
1.7
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
12
18
6.75
7.62
1.9
3.5
u/l
202.7
196.0
0.12
12
18
(3003694) ABO and Rh group [Type] in Blood
343
2644
1.52
7.52
1.9
1.8
—
—
—
0
0
(3009343) pH of Capillary blood
59
272
2.26
7.51
7.1
6.1
ph
7.4
7.4
—
9
26
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
59
274
2.24
7.38
7.1
6.0
kpa
5.2
5.0
0.76
52
257
(3022217) INR in Platelet poor plasma by Coagulation assay
78
405
2.02
7.34
15.9
17.0
inr
1.3
1.2
0.26
13
75
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
21
55
3.89
7.29
1.5
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
172
1139
1.65
7.28
1.3
1.3
u/ml
13.8
8.6
0.34
64
454
(4306422)
32
112
2.93
7.13
1.2
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
84
453
1.95
7.11
4.0
3.9
%
1.1
0.8
0.21
21
100
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
29
96
3.10
7.10
1.5
2.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
21
58
3.69
6.78
1.7
3.8
—
—
—
0
0
(1002224) Polysomnography panel
54
255
2.20
6.51
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
24
75
3.27
6.46
1.8
3.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
666
5995
1.63
6.46
4.6
4.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
29
102
2.91
6.42
2.1
2.6
g/l
128.3
130.8
0.18
24
79
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
41
173
2.44
6.39
13.5
12.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
55
264
2.16
6.37
7.5
6.2
mmol/l
1.9
0.8
1.18
35
183
(3018095) Leukocytes [#/volume] in Urine
290
2217
1.48
6.35
4.0
3.3
e6/l
25.1
79.8
3.43
221
1396
(4062490)
21
61
3.51
6.32
1.1
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
83
466
1.87
6.23
2.2
2.1
e9/l
4.2
4.1
0.16
67
402
(3023511) Choriogonadotropin [Units/volume] in Urine
89
511
1.83
6.23
1.5
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
173
1189
1.58
6.21
1.4
1.3
iu/ml
115.6
24.1
0.45
61
364
(3023323) Follitropin [Units/volume] in Serum or Plasma
101
609
1.75
6.00
1.4
1.4
iu/l
13.6
20.0
1.55
84
520
(3002179) Metamyelocytes/100 leukocytes in Blood
76
420
1.89
5.99
3.6
3.9
%
0.6
0.5
0.12
14
70
(3021440) Promyelocytes/100 leukocytes in Blood
78
435
1.88
5.98
4.1
4.0
%
0.1
0.1
0.61
19
91
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
187
1320
1.54
5.95
1.7
1.5
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
20
59
3.45
5.89
1.1
1.1
ratio
1.1
1.1
—
5
26
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
34
137
2.55
5.85
1.8
1.3
u/ml
2.9
6.6
0.88
15
56
(3007461) Platelets [#/volume] in Blood
797
7649
3.83
5.82
28.6
14.6
e9/l
274.7
262.9
4.93
792
7467
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
18
50
3.66
5.78
1.4
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
19
55
3.51
5.76
1.9
1.6
%
87.3
91.9
1.78
19
55
(3032773) Endomysium IgG Ab [Titer] in Serum
26
92
2.89
5.72
1.1
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
43
196
2.26
5.67
4.2
6.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
28
104
2.75
5.64
1.5
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
18
51
3.59
5.63
1.4
1.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
797
7658
3.75
5.63
28.4
14.5
fl
88.5
89.8
11.87
797
7576
(3024139) IgG subclass 3 [Mass/volume] in Serum
20
61
3.34
5.61
1.2
1.2
g/l
0.4
0.4
0.04
14
42
(3028192) IgG subclass 2 [Mass/volume] in Serum
20
61
3.34
5.61
1.2
1.2
g/l
3.0
2.8
0.20
14
41
(3027135) IgG subclass 1 [Mass/volume] in Serum
20
61
3.34
5.61
1.2
1.2
g/l
5.7
6.1
0.33
14
42
(3035941) MCH [Entitic mass]
797
7659
3.74
5.60
28.4
14.5
pg
29.3
30.0
19.86
797
7575
(3000963) Hemoglobin [Mass/volume] in Blood
797
7666
3.67
5.45
28.8
14.7
g/l
130.2
133.1
10.00
797
7581
(3030905) Polymorphonuclear cells [#/volume] in Blood
32
130
2.52
5.43
2.4
3.2
e9/l
4.1
3.9
0.21
32
130
(3012544) pH of Venous blood
70
390
1.87
5.40
5.8
6.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
47
229
2.12
5.28
1.4
2.1
u/l
33.2
40.6
2.22
37
214
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
46
223
2.13
5.23
2.2
2.1
iu/l
3.1
5.4
1.38
24
88
(3029937) Albumin [Presence] in Urine by Test strip
241
1833
1.45
5.23
4.0
3.3
estimate
0.0
0.0
0.80
123
708
(3015235) Bicarbonate [Moles/volume] in Capillary blood
27
103
2.68
5.19
2.2
3.0
mmol/l
24.9
24.1
0.28
22
91
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
32
133
2.46
5.19
2.7
3.3
%
59.1
55.5
0.88
32
133
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
81
479
1.77
5.15
2.6
2.3
au/ml
34.0
20.3
—
8
30
(3003396) Base excess in Arterial blood by calculation
67
374
1.86
5.14
9.8
8.4
mmol/l
1.9
0.9
1.45
49
280
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
125
833
1.59
5.07
1.9
2.4
mmol/l
2.4
2.4
0.68
106
726
(3025159) Blasts/100 leukocytes in Blood
73
422
1.80
5.01
3.8
4.1
%
0.0
0.2
0.86
15
77
(3024980) IgG subclass 4 [Mass/volume] in Serum
25
94
2.71
4.95
1.3
1.7
g/l
0.4
0.7
1.03
19
70
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
124
2.47
4.93
2.2
2.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
124
2.47
4.93
2.2
2.1
g/l
3.8
3.6
0.16
18
101
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
124
2.47
4.93
2.2
2.1
g/l
7.3
7.3
0.04
20
106
(3002032) Base excess in Venous blood by calculation
68
388
1.82
4.88
5.9
5.9
mmol/l
2.2
1.4
1.25
60
303
(1761868) Lipid panel - Serum or Plasma
307
2463
1.40
4.88
2.5
2.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
76
449
1.76
4.86
1.3
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
119
2.49
4.84
2.3
2.1
g/l
3.0
3.1
0.10
20
103
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
87
538
1.69
4.73
1.1
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
184
1353
1.47
4.71
1.5
1.6
mmol/l
1.2
1.3
0.77
153
1188
(3007853) Bacteria identified in Skin by Aerobe culture
105
684
1.61
4.67
1.7
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
53
3.25
4.63
1.1
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
262
2061
1.40
4.62
1.6
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
29
122
2.43
4.61
1.5
1.6
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
11
25
4.45
4.57
1.3
1.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
639
5830
1.46
4.52
14.0
8.0
ml/min/173m2
93.6
94.2
0.27
526
4574
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
287
2305
1.38
4.44
1.9
1.7
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
94
606
1.62
4.37
1.5
1.6
mu/l
281.1
300.5
0.36
83
534
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
11
26
4.28
4.36
1.0
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
33
151
2.24
4.36
4.1
8.7
mg/l
1.2
1.2
0.10
33
136
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
114
2.42
4.27
2.3
2.1
g/l
9.4
10.2
0.61
21
107
(3036489) Thrombin time
49
263
1.92
4.27
4.6
3.1
s
20.7
21.3
0.59
38
228
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
165
1210
1.46
4.25
2.0
1.8
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
30
134
2.29
4.20
1.6
1.5
mmol/l
6.8
6.6
0.09
15
94
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
9
13
6.99
4.17
1.1
1.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
30
135
2.27
4.13
1.9
1.3
u/ml
5.4
6.8
0.21
16
65
(3000093) Morphology [Interpretation] in Blood Narrative
14
42
3.37
4.05
1.1
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
30
137
2.24
4.00
1.1
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
164
1218
1.43
3.94
1.7
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
34
165
2.11
3.92
1.1
1.1
u/ml
2.9
6.8
0.85
13
66
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
620
5674
1.40
3.90
3.6
2.9
mmol/l
1.2
1.1
0.31
578
5369
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
45
244
1.89
3.83
6.9
7.1
mmol/l
24.7
23.7
1.76
45
221
(3009214) Lutropin [Units/volume] in Serum or Plasma
57
333
1.77
3.82
1.4
1.4
u/l
5.7
10.2
5.98
45
275
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
49
3.10
3.82
1.1
1.4
nmol/l
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
15
50
3.04
3.70
1.5
3.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
118
832
1.49
3.70
2.8
2.7
e6/l
3.2
3.6
0.28
64
437
(3017446) Testosterone [Moles/volume] in Serum or Plasma
45
251
1.84
3.53
2.9
1.9
nmol/l
12.5
9.1
0.36
40
220
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
6
6
10.06
3.50
1.0
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
88
590
1.55
3.49
1.4
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
311
2604
1.32
3.46
1.9
1.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
642
5947
1.39
3.46
3.8
3.2
mmol/l
1.5
1.5
1.55
597
5634
(3000991) Gas panel - Venous blood
56
336
1.72
3.45
13.6
8.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
196
1534
1.37
3.43
2.1
2.0
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
56
337
1.71
3.41
5.8
5.7
kpa
4.5
4.8
0.76
56
325
(3042936) Bacteria identified in Isolate by Culture
100
694
1.50
3.39
2.1
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
244
1981
1.33
3.35
3.0
1.9
—
—
—
0
0
(21494434) Karyotype in Bone marrow
11
32
3.47
3.34
1.3
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
188
1473
1.36
3.26
3.2
3.3
kg/l
1.0
1.0
0.87
31
218
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
36
192
1.92
3.25
1.3
1.4
u/ml
6.0
14.3
—
5
38
(3029396) Erythrocyte agglutination [Presence] in Blood
16
60
2.70
3.24
3.8
3.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
648
6038
1.37
3.15
4.1
3.4
mmol/l
2.7
2.8
2.81
600
5695
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
18
73
2.50
3.14
1.1
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
642
5975
1.36
3.13
3.9
3.2
mmol/l
4.6
4.7
3.72
599
5673
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
78
523
1.54
3.11
2.2
2.2
u/l
143.1
29.7
0.51
69
434
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
112
2.18
3.09
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
112
2.18
3.09
1.3
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
8
7.55
3.06
1.5
1.4
—
—
—
0
0
(4268621)
22
100
2.23
3.02
3.5
2.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
33
176
1.91
2.99
1.7
2.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
94
2.27
2.98
7.8
5.4
u/ml
0.4
0.4
0.15
14
47
(3024891) Influenza virus A+B Ag [Presence] in Specimen
40
228
1.79
2.96
1.3
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
40
228
1.79
2.96
2.2
2.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
35
3.17
2.94
2.4
17.0
%
10.6
11.0
0.14
11
35
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
30
3.36
2.91
1.1
2.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
30
3.36
2.91
1.1
2.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
16
64
2.53
2.88
2.7
2.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
26
130
2.03
2.83
1.3
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
26
130
2.03
2.83
1.3
1.2
—
—
—
0
0
(3000492) Spirometry study
86
602
1.48
2.82
1.3
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
17
71
2.42
2.81
1.1
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
53
2.67
2.80
1.6
2.0
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
42
248
1.73
2.78
1.1
1.2
u/ml
2.0
2.1
0.01
14
96
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
10
31
3.25
2.78
1.2
1.0
u/ml
44.3
53.6
—
10
31
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
35
196
1.82
2.76
1.7
1.6
mmol/l
8.0
7.1
0.73
13
120
(3024522) Salmonella sp identified in Specimen by Organism specific culture
17
72
2.39
2.74
1.1
1.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
14
5.03
2.73
2.3
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
26
132
2.00
2.73
1.4
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
17
73
2.36
2.66
1.1
1.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
17
73
2.36
2.66
5.5
9.3
%
58.9
64.8
0.46
17
73
(3025468) Yersinia sp identified in Specimen by Organism specific culture
17
73
2.36
2.66
1.1
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
110
816
1.40
2.65
1.6
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
24
120
2.03
2.63
1.1
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
31
170
1.86
2.62
1.2
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
33
185
1.82
2.60
1.1
1.1
u/ml
0.5
7.7
2.95
13
70
(3022313) Gas panel - Capillary blood
35
200
1.78
2.60
10.8
6.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
17
74
2.33
2.59
1.1
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
58
380
1.57
2.59
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
31
171
1.85
2.58
1.2
1.1
—
—
—
0
0
(4146454)
8
20
4.03
2.57
2.8
3.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
7
7.18
2.55
1.0
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
11
5.49
2.54
5.2
2.9
—
—
—
0
0
(3019225) pH of Specimen
62
415
1.53
2.53
5.4
3.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
89
646
1.42
2.43
1.6
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
27
146
1.88
2.40
1.3
1.9
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
14
58
2.44
2.38
1.2
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
24
125
1.95
2.37
1.3
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
16
71
2.28
2.35
1.2
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
63
431
1.50
2.34
1.9
2.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
36
215
1.71
2.32
1.1
1.1
u/ml
0.1
2.7
—
8
56
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
15
65
2.33
2.32
1.5
1.2
u/ml
0.3
0.6
—
7
20
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
9
28
3.24
2.31
1.2
1.2
pmol/l
13.4
12.8
—
9
22
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
25
440
0.55
2.26
1.3
1.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
41
256
1.63
2.25
1.7
1.5
nmol/l
0.5
0.5
0.14
35
219
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
15
66
2.30
2.25
1.2
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
66
2.30
2.25
1.7
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
98
735
1.38
2.23
1.3
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
19
3.71
2.15
1.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
131
1035
1.32
2.13
1.9
2.1
—
—
—
0
0
(4027681)
13
55
2.39
2.13
1.3
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
37
229
1.65
2.12
2.2
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
12
49
2.47
2.11
1.6
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
27
153
1.79
2.10
2.4
2.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
80
587
1.40
2.08
1.7
1.8
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
14
62
2.28
2.08
2.1
2.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
39
246
1.62
2.08
1.4
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
9
31
2.92
2.07
1.1
1.1
%
91.6
84.8
—
9
31
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
31
2.92
2.07
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
31
2.92
2.07
1.6
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
72
979
0.71
2.07
1.2
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
80
588
1.40
2.06
1.7
1.8
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
29
169
1.74
2.06
1.4
1.9
mg/l
397.3
422.1
0.18
24
160
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
27
154
1.78
2.06
1.3
1.9
e6/l
15.5
25.3
0.23
17
119
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
27
154
1.78
2.06
1.3
1.9
e6/l
4322.1
72.4
0.68
17
123
(3003888) Timothy IgE Ab [Units/volume] in Serum
36
223
1.64
2.06
1.1
1.1
u/ml
3.4
5.8
0.64
12
128
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
23
125
1.86
2.04
1.8
1.5
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
15
4.02
2.04
2.0
2.1
ug/l
66.2
56.5
—
6
15
(3027008) Opiates [Presence] in Urine
80
590
1.39
2.03
1.4
1.8
—
—
—
0
0
(4198724)
11
44
2.52
2.01
3.5
2.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
90
2.02
2.01
2.2
2.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
9
32
2.83
2.00
1.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
80
592
1.39
1.99
1.7
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
77
2.10
1.97
1.2
1.5
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
12
51
2.37
1.95
1.0
1.1
—
13.2
—
0
5
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
11
4.57
1.94
2.8
6.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
16
3.77
1.93
1.5
1.5
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
34
2.67
1.87
4.3
3.1
u/ml
678.0
869.5
—
9
34
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
116
919
1.31
1.86
1.7
1.6
%
1.4
1.4
0.02
98
837
(3014599) Egg white IgE Ab [Units/volume] in Serum
18
93
1.96
1.86
1.1
1.1
u/ml
0.2
2.9
—
7
28
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
12
4.19
1.82
1.6
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
12
4.19
1.82
1.6
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
12
4.19
1.82
1.6
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
12
4.19
1.82
1.2
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
35
2.59
1.80
5.9
3.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
44
297
1.51
1.79
1.6
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
26
155
1.70
1.74
1.3
1.9
mmol/l
3.7
3.6
0.34
20
145
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
30
2.68
1.72
1.0
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
11
48
2.31
1.71
1.2
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
26
156
1.69
1.71
1.0
1.0
u/ml
0.0
0.1
—
5
36
(3008401) Mugwort IgE Ab [Units/volume] in Serum
33
212
1.58
1.67
1.0
1.1
u/ml
0.8
0.6
0.15
12
96
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
17
90
1.91
1.66
1.2
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
16
83
1.95
1.65
3.3
4.2
u/ml
25.5
91.8
—
6
29
(3011412) CD3 cells [#/volume] in Blood
14
69
2.05
1.65
1.5
2.9
e9/l
1.1
1.6
—
9
43
(3012441) Differential panel - Pleural fluid
7
25
2.82
1.65
1.0
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
8
32
2.51
1.60
4.5
3.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
72
545
1.35
1.60
1.8
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
26
2.71
1.58
1.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
26
2.71
1.58
3.4
2.3
umol/l
16.1
13.8
—
7
26
(4035726)
57
416
1.40
1.58
1.6
1.4
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
15
3.35
1.52
1.4
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
15
3.35
1.52
1.2
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
21
2.87
1.51
1.5
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
79
1.92
1.50
1.6
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
132
1.69
1.47
1.3
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
62
466
1.36
1.45
1.9
1.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
108
878
1.27
1.45
2.7
2.5
e6/l
0.5
1.5
0.95
53
475
(3004451) EKG impression Narrative
5
16
3.14
1.44
1.0
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
39
2.32
1.43
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
39
2.32
1.43
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
39
2.32
1.43
2.3
3.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
54
398
1.38
1.43
1.5
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
21
126
1.68
1.41
1.9
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
62
469
1.35
1.40
1.4
1.3
miu/ml
306.6
245.2
0.50
27
252
(4010399)
47
340
1.41
1.39
1.4
1.4
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
13
67
1.96
1.39
1.0
1.1
mg/l
200.2
237.0
—
6
59
(3024928) Oxygen saturation in Venous blood
16
89
1.81
1.38
5.4
8.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
41
2.21
1.37
1.1
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
41
2.21
1.37
1.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
23
2.62
1.37
1.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
24
152
1.60
1.33
1.1
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
24
2.51
1.30
1.2
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
43
2.11
1.30
7.1
4.7
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
34
2.37
1.29
1.1
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
18
2.79
1.28
1.2
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
25
2.41
1.24
1.5
1.4
—
—
—
0
0
(4211845)
8
36
2.23
1.24
4.5
3.0
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
13
70
1.87
1.24
1.0
1.1
mg/l
88.4
39.0
—
7
54
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
11
56
1.98
1.22
1.3
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
10
49
2.05
1.22
3.4
2.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
16
93
1.73
1.22
2.8
2.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
19
2.64
1.21
3.6
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
19
2.64
1.21
1.0
1.6
—
—
—
0
0
(44790047)
13
71
1.84
1.20
1.8
1.4
—
—
—
0
0
(44806118)
13
71
1.84
1.20
1.8
1.4
—
—
—
0
0
(44790048)
13
71
1.84
1.20
1.8
1.4
—
—
—
0
0
(44790049)
13
71
1.84
1.20
1.8
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
59
754
0.77
1.19
1.6
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
59
753
0.77
1.18
1.6
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
10
50
2.01
1.17
1.7
1.5
promille
0.7
1.3
—
10
37
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
34
0.00
1.16
0.0
1.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
15
87
1.74
1.15
2.1
1.8
—
18.4
—
0
5
(3009871) Measles virus Ab [Titer] in Serum
5
20
2.51
1.15
1.6
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
168
1467
1.18
1.14
2.9
1.9
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
12
65
1.86
1.14
1.0
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
14
80
1.76
1.13
1.1
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
7
30
2.34
1.12
1.0
1.3
g/l
34.8
34.2
—
7
24
(3008295) Osmolality of Serum or Plasma
10
51
1.97
1.11
1.8
1.7
mosm/kgh2o
287.9
283.7
—
10
40
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
31
2.27
1.10
1.3
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
66
1.83
1.09
1.3
1.5
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
21
2.39
1.09
1.0
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
1.0
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
32
2.20
1.08
1.4
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
34
245
1.40
1.07
2.7
2.3
ug/l
15.1
5.6
0.49
27
217
(3049717) Cytology report of Urine Cyto stain
16
97
1.66
1.07
1.8
2.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
60
753
0.78
1.06
1.6
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
48
620
0.76
1.06
1.6
1.5
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
44
332
1.34
1.06
1.3
1.3
ug/l
2.4
3.5
2.47
44
311
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
60
750
0.78
1.04
1.6
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
13
75
1.75
1.03
1.6
2.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
34
2.07
1.03
5.6
9.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
26
180
1.46
1.01
1.8
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
34
248
1.39
1.01
3.0
2.7
e6/l
0.1
0.1
0.39
34
241
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
51
1.77
0.94
1.1
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
27
2.23
0.93
1.0
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
29
209
1.40
0.93
1.1
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
12
70
1.73
0.93
1.3
1.3
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
14
86
1.64
0.91
1.0
1.1
u/ml
0.4
5.0
—
7
28
(3005033) Fetal Nuchal fold Thickness US
49
616
0.78
0.90
1.6
1.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
24
168
1.44
0.90
1.2
1.1
au/ml
6.9
8.5
—
5
15
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
67
549
1.24
0.90
3.4
3.1
%
32.8
32.9
0.04
42
394
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
20
135
1.49
0.90
3.3
2.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
29
211
1.39
0.89
1.6
1.6
iu/ml
0.3
0.4
—
9
35
(3014765) Yersinia sp identified in Stool by Organism specific culture
29
211
1.39
0.89
1.1
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
29
2.08
0.89
1.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
42
1.91
0.88
7.1
2.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
29
391
0.73
0.88
1.9
3.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
13
79
1.66
0.88
1.2
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
43
335
1.30
0.86
3.3
4.0
ug/l
4.0
30.7
0.61
34
244
(3043238) Trisomy 21 risk [Likelihood] in Fetus
51
633
0.79
0.86
1.6
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
63
516
1.24
0.85
4.6
4.4
ug/l
1.6
2.6
0.91
55
462
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
72
1.68
0.85
1.8
1.3
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
15
96
1.57
0.84
1.5
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
29
214
1.37
0.83
1.1
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
58
1.73
0.80
1.1
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
33
1.82
0.79
2.7
2.9
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
6
33
1.82
0.79
2.0
2.6
e9/l
0.1
0.1
—
6
33
(3011397) Hemoglobin [Presence] in Urine by Test strip
171
1544
1.14
0.76
3.4
3.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
70
826
0.83
0.75
1.6
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
54
1.67
0.74
1.4
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
9
55
1.64
0.73
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
36
455
0.78
0.72
3.2
2.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
40
1.76
0.71
1.9
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
87
753
1.17
0.70
1.5
1.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
9
58
1.56
0.70
1.1
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
59
1.53
0.68
1.7
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
31
241
1.30
0.67
1.3
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
70
1.58
0.65
1.5
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
120
1.43
0.65
1.4
1.3
—
—
—
0
0
(4094501)
14
95
1.48
0.64
1.0
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
14
95
1.48
0.64
1.3
1.5
—
71.6
—
0
9
(3034426) Prothrombin time (PT)
5
29
1.73
0.64
3.0
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
17
121
1.41
0.62
1.3
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
10
63
1.59
0.62
2.1
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
16
113
1.42
0.61
1.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
21
0.00
0.60
0.0
2.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
35
1.72
0.57
1.2
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
70
608
1.17
0.56
2.0
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
219
2045
1.10
0.55
2.8
2.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
26
204
1.28
0.54
1.4
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
28
222
1.27
0.54
1.2
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
25
313
0.79
0.50
1.4
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
65
1.39
0.50
1.6
2.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
65
1.39
0.50
1.1
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
23
180
1.29
0.50
2.4
5.5
g/l
0.3
0.4
0.41
13
70
(3014007) Fractional oxyhemoglobin in Arterial blood
25
198
1.27
0.50
18.6
9.9
%
94.2
94.3
0.03
25
198
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
47
1.49
0.47
1.1
1.6
g/l
0.8
0.9
—
7
47
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
33
1.52
0.41
1.2
1.9
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
3.3
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
0.4
—
0
11
(21494815) CD4 cells/100 lymphocytes in Specimen
8
59
1.36
0.41
1.9
2.5
—
43.5
—
0
6
(1761482) Bacteria [#/volume] in Urine by Culture
15
114
1.32
0.41
2.3
3.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
12
160
0.75
0.40
1.8
1.8
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
35
1.43
0.39
2.2
2.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
35
1.43
0.39
1.2
1.4
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
80
1.38
0.38
1.7
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
47
414
1.14
0.35
3.9
4.1
%
22.1
20.4
0.33
16
179
(3006598) pH of Arterial cord blood
6
43
1.40
0.35
1.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
91
1.32
0.34
1.8
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
12
91
1.32
0.34
1.2
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
25
294
0.85
0.31
2.1
1.7
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
24
202
1.19
0.31
19.3
9.6
%
1.3
1.4
0.39
24
202
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
48
536
0.89
0.31
5.1
5.0
—
—
—
0
0
(44813793)
7
54
1.30
0.30
1.0
1.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
24
203
1.19
0.30
19.3
9.7
%
0.6
0.7
0.52
24
203
(3004716) Salmonella sp identified in Stool by Organism specific culture
62
564
1.11
0.29
1.1
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
24
277
0.86
0.25
2.7
2.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
43
391
1.11
0.22
2.0
2.2
ml/min/173m2
72.9
78.8
0.37
18
134
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
5
41
1.22
0.22
1.0
1.7
—
73.7
—
0
6
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
42
1.19
0.21
1.0
1.1
miu/ml
788.4
1632.8
—
5
42
(4133840)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
1.2
—
0
6
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
43
1.16
0.21
1.0
1.5
—
—
—
0
0
(4034850)
20
173
1.16
0.21
5.9
8.9
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
187
0.85
0.20
1.9
1.8
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
6
49
1.23
0.20
1.0
1.0
mu/l
7.4
8.5
—
6
44
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
234
2273
1.04
0.19
3.0
2.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
71
668
1.07
0.18
1.9
1.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
12
100
1.20
0.18
2.3
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
152
0.85
0.17
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
72
1.11
0.16
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
72
1.11
0.16
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
72
1.11
0.16
1.3
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
34
313
1.09
0.15
1.4
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
80
1.13
0.15
1.1
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
83
1.09
0.14
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
86
0.81
0.14
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
34
314
1.09
0.14
3.4
2.8
ug/l
0.7
0.7
0.04
21
199
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
18
201
0.89
0.13
2.2
1.9
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
28
257
1.09
0.13
1.4
2.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
39
365
1.07
0.12
2.0
2.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
23
212
1.09
0.10
1.1
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
20
218
0.92
0.10
1.8
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(4281824)
5
46
1.09
0.09
1.2
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
33
350
0.94
0.09
1.3
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
48
1.04
0.09
1.4
1.9
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
48
1.04
0.09
1.0
1.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
48
1.04
0.09
1.2
1.5
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
48
1.04
0.09
1.0
3.2
u/ml
17.4
66.1
—
5
48
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
14
155
0.90
0.09
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
54
1.11
0.09
1.7
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
57
1.05
0.08
2.0
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
57
1.05
0.08
1.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
58
1.03
0.08
1.7
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
67
1.05
0.08
2.0
2.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
19
176
1.08
0.07
1.3
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
103
0.87
0.06
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
15
139
1.08
0.05
4.1
4.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
13
122
1.07
0.02
1.2
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
132
1.06
0.02
2.6
3.7
mg/l
28.7
26.7
—
6
83
(40768793) Breast Pathology biopsy report
18
185
0.97
0.00
1.4
1.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
71
0.99
0.00
1.3
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
17.9
—
0.5
—
0
9
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
7.6
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
7
0.00
0.00
0.0
1.1
—
37.5
—
0
7
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
71
0.99
0.00
1.3
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
6
0.00
0.00
0.0
5.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
7
0.00
0.00
0.0
1.1
—
57.1
—
0
7
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
71
0.99
0.00
1.3
1.2
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_FE_DEF and mortality.

Females

Parameter HR [95% CI] p-value
E4_FE_DEF 2.095 [1.24, 3.53] 0.006
Birth year 0.991 [0.98, 1.0] 0.05

During the follow-up period (1.1.1998 — 31.12.2019), 86 out of 757 females with E4_FE_DEF died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have E4_FE_DEF.

N-year risk Females Males
1 0.187% No data
5 1.011% No data
10 2.722% No data
15 5.249% No data
20 9.096% No data

Relationships between endpoints

↥

Index endpoint: E4_FE_DEF – Iron deficiency

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data